NCT05932472View on ClinicalTrials.gov

Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial

PHASE4RecruitingINTERVENTIONAL

Enrollment

32,706

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

January 15, 2027

Study Completion Date

February 15, 2027

Conditions

AtherosclerosisCardiovascular DiseasesDrug Effect

Interventions

DRUG

Aspirin

Aspirin at currently prescribed dose

Trial Locations (1)

2900

RECRUITING

Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Hellerup

All Listed Sponsors

lead

Tor Biering-Sørensen

OTHER